Brief: AGC Biologics Enters Into Partnership With Ono Pharmaceuticals
13/08/2020 14:12
Aug 13 (Reuters) - Ono Pharmaceutical Co Ltd 4528.T :
* AGC BIOLOGICS ENTERS INTO PARTNERSHIP AS A CDMO WITH ONO
PHARMACEUTICALS TO MANUFACTURE BIOPHARMACEUTICALS AT CLINICAL
DEVELOPMENT STAGE
Source text for Eikon: ID:nPn901bPja
Further company coverage: 4528.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ONO PHARMACEUTICAL
See all newsBrief: Biohaven Enters Strategic Licensing Agreement With Ono Pharma
Ono Pharma Announces An Exclusive License Agreement With Biohaven To Develop And Commercialize Igg Degraders In Japan, South Korea, Taiwan, And Asean
Bristol Myers sues Amgen over proposed Opdivo biosimilar (updated)
Bristol Myers sues Amgen over proposed Opdivo biosimilar
Brief: UK's MHRA Says Vimseltinib Approved For Use In Adults To Treat Tenosynovial Giant Cell Tumours